Urine Monitoring Systems Market size was valued at USD 5.6 billion in 2024 and is estimated to secure a valuation of USD 13.9 billion by the end of 2037, rising at a CAGR of 7.1% during the forecast period, i.e., 2025-2037. In 2025, the industry size of urine monitoring systems is evaluated at USD 6.0 billion.
The urine monitoring systems market is expected to witness a rapid surge due to the rising demand for advanced diagnostic tools across healthcare settings. Innovations such as wireless and non-invasive solutions reshape the landscape and make diagnostics accurate and friendly for patients. For example, Bright Uro raised USD 23 million in Series A funding for developing a catheter-free urodynamics system in December 2023, a recent innovation that points to a shift in the direction of improvement not just of patient comfort but of diagnostic accuracy as well. Governments also emphasize the development of diagnostic solutions and encourage grants and policies to look forward to better prospects of using advanced technologies.
The demand for urine monitoring systems is underpinned by ongoing regulatory support and technological advances in widening the scope of critical care and chronic disease management applications. For example, in September 2024, PreAnalytiX GmbH came up with the PAXgene Urine Liquid Biopsy Set to enable the analytically reliable analysis of cfDNA from urine. This launch highlights the focus of companies on precision diagnostics and non-invasive technologies. Furthermore, governments are contributing by investing in healthcare infrastructure, with various grants that are being used to improve the diagnostic capabilities in various regions across the world, hence improving patient outcomes.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
7.1% |
|
Base Year Market Size (2024) |
USD 5.6 billion |
|
Forecast Year Market Size (2037) |
USD 13.9 billion |
|
Regional Scope |
|
Product Type (Urine Output Monitoring Systems, Urine Analysis Monitoring System, Urine Collection Devices, Others)
The urine analysis monitoring systems segment in urine monitoring systems market is expected to hold a 46% share by 2034, due to the vital role they play in the diagnosis and management of several chronic diseases, such as kidney disorders, diabetes, and urinary tract infections. These systems help healthcare professionals obtain critical diagnostic information for early intervention and treatment. Growth prospects further increased with the advancements in technology. For example, in September 2022, Sysmex Corp. launched an advanced urine particle analyzer-UF-1500-to help raise diagnostic capabilities and productivity through automation. This innovation meets expanding demands for fast, reliable diagnostic solutions within both hospital and outpatient settings.
Usage (Urine Collection Bags (Disposable, Reusable), Urinary Catheter (Disposable, Reusable))
Disposable urine collection bags are expected to hold the largest share of 61% in the urine monitoring systems market by 2034, which could be attributed to the wide utility of the product in hospitals, clinics, and home healthcare settings. Their ease of use, cost-effectiveness, and hygienic design have made them an indispensable tool for treatment, from acute to long-term care. Moreover, this segment is seeing incredible innovations in patient monitoring and data collection. For instance, the world's first self-operating IoT Uroflowmeter that Oruba Technology launched in November 2021 demonstrated how innovations can be integrated into advanced technology on a disposable solution. This, among other similar innovations, places a high demand for innovative products that enhance patient experience and clinical outcomes and fuel urine monitoring systems market dominance of disposable solutions.
Our in-depth analysis of the global market includes the following segments:
|
Product Type |
|
|
Usage |
|
|
Medical Condition |
|
|
End user |
|
North America Market Analysis
North America in urine monitoring systems market is anticipated to account for around 38% revenue share by 2037, driven by innovations in diagnostic technologies and government funding programs. Large investments, such as the United States Department of Agriculture to grant USD 42.3 million for telemedicine infrastructure in 2021, improve healthcare access in the areas. These developments underline the commitment of the region towards better diagnostic capabilities and healthcare delivery. Adoption in both hospitals and outpatient settings is driven by technological innovation and funding support. This satisfies the fact that North America remains at the forefront of the global urine monitoring systems market.
The U.S. dominates North America market owing to substantial investments in innovative healthcare technologies. In January 2023, Starling Medical launched StarStream, an at-home urine diagnostic and monitoring platform. It eliminates the need for containers or dipsticks, offering hassle-free urine testing. The technology provides accurate, real-time diagnostics for healthcare monitoring. Such innovation represents the country's emphasis on patient-oriented solutions and increasing diagnostic precision. These factors position the U.S. as a lucrative market for players looking to expand their product offerings.
Canada is anticipated to witness steady growth in the urine monitoring systems market. Advanced diagnostic technologies are being adopted in Canada healthcare system to improve the clinical outcomes of patients. Government grants for firms operating in diagnostic technologies and partnerships further accelerate the adoption of various types of urine monitoring systems across the country. Such a collaborative approach increases access to novel tools in hospitals and clinics. Besides, the focus on non-invasive diagnostics aligns with Canada objective for better patient-centric care. These factors drive the uptake of advanced urine monitoring solutions within the region.
Asia Pacific Market Analysis
Asia Pacific urine monitoring systems market is expected to register over 7.5% growth till 2037, due to the increasing healthcare needs and awareness about urinary health. Other factors that could enable such major growth are rapid urbanization and expansion of healthcare infrastructures. Addressing unmet diagnostic needs, governments and private entities in the region continue to invest in healthcare innovations. In countries with high prevalence rates of urinary disorders in the region, the demand for advanced urine monitoring solutions is surging, hence opening huge opportunities for expansion and innovation in the market.
China represents a large portion of Asia Pacific urine monitoring systems market due to the high prevalence of conditions concerning the urinary system, driving the need for advanced diagnostics. Increased healthcare expenditures and growing awareness about urinary health are contributing to market growth. Government initiatives support the integration of advanced diagnostic technologies into both urban and rural settings. All these factors put China in a critical position for innovation and adoption.
India is emerging as one of the key urine monitoring systems markets for urine monitoring systems, with support from domestic manufacturers and regulatory approvals. For instance, Status Medical Equipments India received licenses to manufacture advanced urological devices in April 2023. This underlines the growing impetus through which the region makes healthcare more accessible and enhances diagnostic capabilities. Government initiatives and growing investments in healthcare are contributing to the increasing application of these systems. India offers various coveted growth opportunities for both manufacturers and healthcare providers due to its increasing prevalence of urinary conditions.
The nature of competition in the urine monitoring systems market is high, with multiple players such as Accuryn Medical, Becton Dickinson and Company, Beckman Coulter Inc., Cardinal Health, and F. Hoffmann-La Roche Ltd. at the front. These companies invest considerably in research and development to meet the growing demand for diagnostic solutions that are accurate, efficient, and friendly to patients. The innovative approach aids the players in developing advanced technologies that enable the development of leading market positions but also helps them answer emerging healthcare needs.
For example, the introduction of the PAXgene Urine Liquid Biopsy Set by PreAnalytiX GmbH in September 2024 reflects the move of the industry toward diagnostics that are non-invasive and of high value. This latest system for cfDNA analysis from urine emphasizes the growing impetus on better diagnostics and enhancing patient friendliness. These types of product innovations are not only expanding the demand for urine monitoring systems but are also driving improved health outcomes globally.
Here are some leading companies in the urine monitoring systems market:
Author Credits: Abhishek Verma
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?